Abstract-Despite its importance for the regulation of heart function, little is known about the isoform expression of the multifunctional Ca 2ϩ /calmodulin-dependent protein kinase (CaMKII) in human myocardium. In this study, we investigated the spectrum of CaMKII isoforms ␦ 2 , ␦ 3 , ␦ 4 , ␦ 8 , and ␦ 9 in human striated muscle tissue. Isoform ␦ 3 is characteristically expressed in cardiac muscle. In skeletal muscle, specific expression of a new isoform termed ␦ 11 is demonstrated. Complete sequencing of human ␦ 2 cDNA, representing all common features of the investigated CaMKII subclass, revealed its high homology to the corresponding rat cDNA. Comparative semiquantitative reverse transcription-polymerase chain reaction analyses from left ventricular tissues of normal hearts and from patients suffering from dilated cardiomyopathy showed a significant increase in transcript levels of isoform ␦ 3 relative to the expression of glyceraldehyde-3-phosphate dehydrogenase in diseased hearts (101.6Ϯ11.0% versus 64.9Ϯ9.9% in the nonfailing group; PϽ0.05, nϭ6). Transcript levels of the other investigated cardiac CaMKII isoforms remained unchanged. At the protein level, by using a subclass-specific antibody, we observed a similar increase of a ␦-CaMKII-specific signal (7.2Ϯ1.0 versus 3.8Ϯ0.7 optical density units in the nonfailing group; PϽ0.05, nϭ4 through 6). The diseased state of the failing hearts was confirmed by a significant increase in transcript levels for atrial natriuretic peptide (292.9Ϯ76.4% versus 40.1Ϯ3.2% in the nonfailing group; PϽ0.05, nϭ3 through 6). Our data characterize for the first time the ␦-CaMKII isoform expression pattern in human hearts and demonstrate changes in this expression pattern in heart failure. (Circ Res. 1999;84:713-721.)
T he Ca
2ϩ /calmodulin-dependent protein kinase class II (CaMKII) is a multifunctional enzyme 1 involved in the regulation of gene expression, 2 cell cycle control, 3 and differentiation. 4, 5 Alternative splicing of the primary transcripts encoded by 4 genes (␣, ␤, ␥, and ␦) results in the generation of different CaMKII variants. 6, 7 Members of the ␣-and ␤-classes are expressed mainly in neuronal tissue, whereas ␥-and ␦-CaMKII isoforms are abundantly expressed in all tissues. 6, 8, 9 Multifunctionality of the homomultimeric or heteromultimeric holoenzyme composed of 8 through 12 subunits 10 seems to counteract its specific cellular functions. This apparent antagonism is compensated for by controlling the localization of the holoenzyme whereby the isoform composition and its phosphorylation state regulate translocation to different cellular compartments and control the accessibility to substrates. [11] [12] [13] As a major regulator of Ca 2ϩ homeostasis, CaMKII is essential for heart function. The importance of this enzyme class for the myocardium is underlined through established cardiac CaMKII targets. 14 -17 Immunoprecipitation studies have indicated that in the mammalian heart, heteromultimer CaMKII holoenzymes are formed, composed of abundant ␦-isoforms and ␥-subunits, the latter expressed in much lower amounts. 18 Members of the CaMKII ␦-class represent the best characterized cardiac CaMKII isoforms. 8, 9, 19, 20 At the beginning of this study, from the known ␦-isoforms (termed ␦ 1 through ␦ 10 according to Mayer et al 9 ) , the presence of proteins for isoforms ␦ 2 , ␦ 3 , and probably ␦ 9 has been demonstrated in cardiac tissue. 19 -21 Isoform ␦ 3 , which contains a functional nuclear localization signal in its variable domain I, may be involved in the regulation of atrial natriuretic factor (ANF) gene expression 13 and appears to be a dominant isoform in the adult heart. 20, 21 Until now, none of these supposedly highly expressed ␦-CaMKII isoforms has been identified in human myocardium. From studies with noncardiac cells, partial sequences for human isoforms ␦ 2 and ␦ 9 were obtained. 22 Herein we report the identification and expression of individual ␦-CaMKII isoforms in human striated muscle tissues. We demonstrate the presence of large amounts of transcripts for isoforms ␦ 2 , ␦ 3 , ␦ 8 , and ␦ 9 in human cardiac tissue, and we have been able to detect a new isoform, termed ␦ 11 , specifically expressed in human skeletal muscle tissue. Sequencing of the complete ␦ 2 -CaMKII cDNA demonstrates a high degree of homology to the corresponding rat isoform.
In most cases of heart failure, systolic and diastolic dysfunction is caused by abnormalities in Ca 2ϩ handling systems. [23] [24] [25] To prove whether this mechanism also holds true for the CaMKII system, we compared the ␦-CaMKII isoform pattern of normal left ventricular tissues with corresponding tissue from patients suffering from dilated cardiomyopathy (DCM). As a marker for the diseased state, 26, 27 we determined the transcript levels for ANF in parallel. We demonstrate in this article the increased expression of isoform ␦ 3 at the transcriptional level and of the subclass of ␦-CaMKII isoforms, to which isoform ␦ 3 belongs, at the protein level in the failing compared with nonfailing myocardium and suggest that these changes are linked to heart failure.
Materials and Methods

Tissue Samples and Histomorphology
Human cardiac tissue samples were obtained from the German Heart Institute, Berlin, Germany, and a sample of human thigh skeletal muscle was obtained from the Robert-Rössle Clinic, Berlin-Buch, Germany. Cardiac tissue samples were taken from the apical part of the left ventricular free wall from hearts not accepted for transplantation (nonfailing hearts) and from explanted DCM hearts from age-matched groups (meanϮSEM age in years in the nonfailing group, 48.3Ϯ3.1; in the DCM group, 50.7Ϯ3.3; see also Table 2 ). Immediately after preparation, the tissue samples for isolation of RNA or protein were frozen in LN 2 and stored at Ϫ80°C. For preparation of histological slides, tissue samples were embedded in paraffin and stained with hematoxylin/eosin and Domagk for the demonstration of connective tissue. The size of heart muscle cells, textural organization of heart muscle cells, grading of hypertrophy, and distribution and volume of connective tissue were determined in a standardized protocol. 28 In nonfailing hearts, the sizes of heart muscle cells were in the normal range (diameter of cardiomyocytes Ͻ14.9 m) or only slightly enlarged (Ͻ16.9 m). In the DCM group, corresponding values ranged above normal levels (Ͼ17 m, with some values Ͼ20 m). Permission for the procurement of human tissue samples was granted by the German law of transplantation of December 1997 and/or the personal decision of the organ donor.
Extraction of RNA
Total RNA from human muscle tissue was extracted according to Kingston et al. 29 After isolation, the remaining DNA contaminants were digested in 40 mmol/L Tris-HCl (pH 7.5), 6 mmol/L MgCl 2 , and 10 L of RNase-free DNaseI (Pharmacia) for 10 minutes at 37°C in a total volume of 100 L. RNA was reextracted with the RNA clean-up procedure of the RNeasy system (Qiagen). Total digestion of genomic DNA was assessed by polymerase chain reaction (PCR) without the reverse transcription (RT) step.
Reverse Transcription-Coupled Polymerase Chain Reaction
For RT, the RNA solution was boiled and immediately chilled on ice. Random-primed cDNA synthesis for PCR was carried out in a total volume of 60 L containing up to 6 g of total RNA in the presence of 6 L of 10ϫ PCR buffer (Eurogentec), 4.8 L of 25 mmol/L MgCl 2 , 16 L of dNTP (2.5 mmol/L of each nucleotide; US Biochemical), 1.5 L of RNase inhibitor (RNAguard, Pharmacia), 1.5 L of 10ϫ hexanucleotide mix (Boehringer), and 3 L of Superscript II RNaseH -reverse transcriptase (Gibco BRL). After incubation for 10 minutes at room temperature, RT was performed for 1 hour at 42°C. For each PCR, an aliquot of the RT reaction mixture equivalent to that originally containing 500 ng of total RNA was used. The volume of this aliquot was increased to 100 L and then to a final amount of 10 L of 10ϫ PCR buffer, 8 L of 25 mmol/L MgCl 2 , 4 L of dNTP, 50 pmol of each specific primer (Table 1) , and, in the case of the standard protocol, 0.2 L of thermostable DNA polymerase (GoldStar red DNA polymerase, Eurogentec). Standard PCR was performed in a TRIO thermocycler (Biometra) as follows: 3 minutes at 94°C for the denaturation step; 19 cycles for GAPDH-specific amplification in the linear range, 24 cycles for ␦-CaMKII-specific amplifications in the linear range, or All primers were purified by high-performance liquid chromatography and purchased from BioTez. *Cited are References or GenBank accession numbers. †Described in this article.
36 cycles of amplification (30 seconds at 94°C, 1 minute at 55°C, and 1 minute at 72°C); and a final 7-minute elongation step at 72°C. For amplification of ANF, a hot-start PCR protocol was established, starting with a 5-minute denaturation step at 95°C; a 4-minute rest at 80°C (during this time, 0.2 L of thermostable DNA polymerase was added to the amplification reactions) followed by 19 cycles of amplification (30 seconds at 95°C, 1 minute at 58°C, and 1 minute 30 seconds at 72°C); and a final 14-minute elongation step at 72°C. After PCR, 8 L of the 100-L reaction mixture was loaded onto 2% agarose gels containing ethidium bromide. As the size marker for gel electrophoresis, a ready-load 100-bp DNA standard (Gibco BRL) was used. After agarose gel electrophoresis, stained DNA bands were visualized under UV light. Background-subtracted optical density (OD) units from peak areas were obtained with the PCBas system (raytest Isotopenme␤geräte GmbH). For comparison of different reactions, GAPDH-specific PCRs were carried out in parallel.
Extraction of PCR Fragments From Agarose Gels and Sequencing of PCR Products
For sequencing, amplification products were loaded onto 2% ethidium bromide-containing agarose gels, and the band of interest was cut out. Extraction of DNA from the gel slice was done with the Qiaquick gel-extraction kit (Qiagen) according to the manufacturer's instructions. Standard cycle sequencing reactions were performed commercially by InViTek (Berlin-Buch, Germany).
Preparation of Total Homogenates and Western Blotting
Approximately 30 mg of tissue was homogenized in a 10-fold volume of homogenization buffer consisting of (in mmol/L) HEPES 10 (pH 7.5), PMSF 0.2, and DTT 0.1, and 1 mg/L leupeptin with an Ultra Turrax T5 FU homogenizer (Janke & Kunkel) for 3ϫ 10 seconds at 50 000 rpm. Homogenate protein was solubilized in the same volume of 2ϫ concentrated SDS sample buffer and electrophoresed through SDS polyacrylamide gels. 30 Separated proteins were electrotransferred onto polyvinylidenedifluoride membranes. Processing for immunoblotting was performed as described in Towbin et al. 31 A ␦-subclass-specific antibody recognizing ␦-CaMKII isoforms that contained variable domain II was used as described in Hoch et al. 20 For immunoblotting, the antibody was diluted to 1 g/mL. A specific antibody detecting sarcoplasmic reticulum Ca 2ϩ -ATPase (BioMol) was prepared to a final dilution of 1:1000. For detection, the secondary antibodies were anti-rabbit IgG (␦-CaMKII) and anti-mouse IgG (sarcoplasmic reticulum Ca 2ϩ -ATPase) (both obtained from Sigma) conjugated with peroxidase. The immunoreaction was visualized using the enhanced chemoluminescence kit (Amersham) and autoradiography on x-ray film. Densitometric analyses of autoradiograms were performed with the PDI imaging system (PDI). Data for protein bands were expressed relative to the myosin heavy-chain band (205 kDa) obtained by densitometrically scanning the polyvinylidenedifluoride membranes stained with Ponceau S (Sigma) to correct for differences in muscle protein content between heart tissue homogenates.
Statistical Evaluation
Results are given as meanϮSEM. Mean values were compared using the unpaired t test when the check for a normal distribution was positive and the Mann-Whitney U test otherwise. A value of PϽ0.05 was assumed to be statistically significant.
Results
␦-CaMKII Isoforms in Human Striated Muscle Tissue
To identify human cardiac ␦-CaMKII isoforms, we performed RT-PCR studies with isoform-specific primer combinations (Table 1) . ␦-CaMKII contains 2 variable regions. Variable domains I are identical between isoforms ␦ 2 /␦ 6 , ␦ 3 /␦ 7 , ␦ 4 /␦ 8 , and ␦ 9 /␦ 10 . 9 Variable domain II is a C-terminal extension present in isoforms ␦ 2 , ␦ 3 , ␦ 4 , and ␦ 9 but lacking in isoforms ␦ 6 , ␦ 7 , ␦ 8 , and ␦ 10 . Isoforms ␦ 1 and ␦ 5 , exclusively neuronally expressed in the rat, 9 are not considered in this study. Using primer combinations specific for isoforms containing both variable regions, we obtained signals from human heart in the sizes expected for isoforms ␦ 2 , ␦ 3 , and ␦ 9 ( Figure 1A, left) . As a positive control for isoform ␦ 4 , a skeletal muscle-specific isoform in rat, and as a negative control for isoform ␦ 3 , an isoform undetectable in rat skeletal muscle tissue, 8 we amplified cDNAs derived from human skeletal muscle tissue ( Figure 1A, right) . Figure 1A) .
To our surprise, we obtained a skeletal muscle-derived signal for isoform ␦ 3 when we used a forward primer that specifically detects variable domain I of this isoform. This amplification product is set in brackets in Figure 1A , because it seemed to be slightly larger than that derived from cardiac muscle (ie, compare the vertical distances in the corresponding lanes between isoforms ␦ 2 and ␦ 3 in Figure 1A ). Sequencing of this skeletal muscle-derived amplification product revealed an insertion of 42 bp between the variable region I specific for isoform ␦ 3 and the conserved 3Ј part of ␦-CaMKII. This 42-bp insert codes for 14 amino acid residues characteristic of variable region I of isoform ␦ 9 . The newly identified ␦-CaMKII isoform was named ␦ 11 ( Figure  1B, top) . We generated a primer specific for detection of this yet-undescribed ␦-CaMKII isoform. Whereas isoform ␦ 11 is near the detection limit when cardiac tissue is used, sufficient amplification products were obtained with skeletal muscle tissue ( Figure 1B, bottom) .
Complete cDNA Sequence of Human ␦ 2 -CaMKII
Tombes and Krystal 22 identified 329 nucleotides of human ␦ 2 -CaMKII-specific sequences (Figure 2, underlined) . Our amplification products for isoforms ␦ 2 , ␦ 3 , ␦ 9 , and ␦ 11 ( Figure  1) include the conserved C-terminal part of the kinase, including variable region II, to the stop codon (Figure 2 , dotted line). To obtain amplification products for the missing N-terminal part of the kinase, we used forward primer P16, which is derived from amino acid residues 1 to 8 of the corresponding cDNA from the rat. 6 This primer was used in combination with reverse primer P44 (Figure 2, arrows) . RT-PCR of human cardiac RNA resulted in amplification of a 984-bp product. The sequence of this product is set in boldface letters in Figure 2 . Thus, we obtained the complete cDNA sequence of human ␦ 2 -CaMKII. Alignment with the corresponding cDNA sequence from the rat showed a 92.6% identity with respect to nucleotides and a 98.9% identity at the protein level.
Comparison of ␦-CaMKII Isoform Pattern in Failing and Nonfailing Human Myocardium
To compare the amounts of transcripts of individual ␦-CaMKII isoforms from failing and nonfailing hearts in a semiquantitative assay, we used GAPDH transcripts as the standard for normalization. As an additional marker of the diseased state, we determined ANF transcript levels in parallel. The RT reactions for analysis of the CaMKII isoforms, ANF, or GAPDH from 1 tissue sample were carried out in the same reaction tube. For PCR, identical aliquots of cDNA were used (see Materials and Methods). For comparison of amplification products, the signals should be in the Table 1 ). Specificity of the single amplification products was also confirmed by sequencing. Skeletal muscle-derived signal obtained with the ␦ 3 -specific primer combination is set in brackets; sequencing revealed its identity as isoform ␦ 11 . (The nucleotide sequence reported in this article has been submitted to the GenBank/EMBL Data Bank with accession number AF071569.) Positions of signals derived from the marker (M) and a lane containing buffer control (C; PCR without nucleic acid) are included. B, Positions and orientations of primers generated for specific amplification of isoform Complete coding sequence of human ␦ 2 -CaMKII and alignment with homologous sequence from rat. 6 Differences between both sequences resulting in changes at the protein level are boxed. Sequence fragment as obtained from Tombes and Krystal 22 for human ␦-CaMKII isoform ␦ 2 from noncardiac cells is underlined. The dotted line marks the sequence of the 3Ј-terminal region of the kinase derived from sequencing of amplification products shown in Figure 1 . The N-terminal part of human ␦ 2 -CaMKII is set in boldface type and was obtained by sequencing the amplification product obtained with primer combination P16/P44 (positions and orientations marked by arrows) from human left ventricular tissue. A peptide with the amino acid sequence KENFSGGTSLWQNI derived from the C-terminal end of the kinase was used for generating a subclass-specific antibody. 20 linear range of the amplification reaction. We therefore determined the cycle dependence for amplification of GAPDH and ␦ 9 -CaMKII from nonfailing tissue samples and for ANF from DCM hearts, because in these tissues high levels of the corresponding signals are expected. Isoform ␦ 9 was chosen because, together with isoforms ␦ 2 and ␦ 3 , it appeared to be 1 of the strongest signals obtained ( Figure  1A) . The upper part of Figure 3 shows the result of amplification of GAPDH, ANF, and ␦ 9 -CaMKII from cycles 15 to 40 for 3 independent reactions. Data from these experiments are shown in the lower part of Figure 3 . After examining these data, we therefore used 19 cycles for amplification of GAPDH-and ANF-specific products and 24 cycles for amplification of ␦-CaMKII-specific products because they appeared to be within the linear ranges of their respective reactions for semiquantitatively assaying transcript levels of ␦-CaMKII and ANF in human heart samples. In Figure 4A , representative RT-PCRs for isoform ␦ 3 , ANF, and GAPDH from 3 nonfailing and 6 diseased hearts are presented. Figure  4B shows the statistical evaluation of similar experiments as shown in Figure 4A . Comparison of the isoform pattern normalized to GAPDH expression ( Figure 4B ) revealed a significant increase in the amount of transcript of isoform ␦ 3 in the diseased hearts (101.6Ϯ11.0% versus 64.9Ϯ9.9% in the nonfailing group; PϽ0.05, nϭ6 individual hearts). As expected from Northern blotting data published by Arai et al, 27 the amount of transcript for ANF was significantly increased in the DCM group (292.9Ϯ76.4% versus 40.1Ϯ3.2% in the nonfailing group; PϽ0.05, nϭ3 through 6), confirming the nonfailing and diseased states of the investigated groups. Transcript levels of the other analyzed cardiac CaMKII isoforms remained unchanged. Table 2 To analyze ␦-CaMKII expression at the protein level in failing and nonfailing human myocardium, an antibody was used that recognizes ␦-CaMKII isoforms from rat that contain variable domain II. 20 By reason of the identity between rat and human ␦-CaMKII in this region (Figure 2) , the antibody detects signals derived from the corresponding ␦-isoforms in human hearts ( Figure 5, upper left) . On immunoblots, similar to what has been observed in rat hearts, 20 there is a faint band below the major signal that corresponds in size to isoform ␦ 2 . The major signal corresponds in size to the molecular masses of isoform ␦ 3 (57.7 kDa) 21 and ␦ 9 , which differs from ␦ 3 by only 3 amino acids. 9 Statistical evaluation of data from 4 independent RT-PCRs with RNA isolated from 2 nonfailing hearts (␦ 9 -and GAPDH-specific products) or 3 diseased hearts (ANF-derived products) are shown. Specificity of ANF-specific amplification product was also confirmed by sequencing. Statistical evaluation of the gels is shown in the lower part and reveals cycle numbers (24 for ␦ 9 and 19 for GAPDH, ANF; marked by asterisks) that were used for amplification of the corresponding products in the linear range for the subsequent experiments.
nonfailing and 6 failing hearts revealed a significant increase in this main signal in tissue samples from DCM hearts (7.2Ϯ1.0 versus 3.8Ϯ0.7 OD units in nonfailing hearts, PϽ0.05) ( Figure 5, lower left) . Because the amount of transcript for isoform ␦ 9 was found to be unchanged (Table  2) , we propose that the increase in the ␦-CaMKII protein signal results from an increase in the expression of isoform ␦ 3 .
In the same tissue samples, we analyzed the expression of sarcoplasmic reticulum Ca 2ϩ -ATPase. A representative immunoblot is shown in the upper right portion of Figure 5 . A statistical evaluation of 4 through 6 independent experiments is shown in the lower portion of Figure 5 (right), and this revealed a significant decrease in sarcoplasmic reticulum Ca 2ϩ -ATPase in the DCM group (1.5Ϯ0.5 versus 3.6Ϯ0.6 OD units in nonfailing hearts, PϽ0.05).
Discussion
This is the first report on the identification of the ␦-CaMKII isoform pattern at the transcriptional level in the adult human heart. By comparison with the ␦-CaMKII isoform patterns in human skeletal muscle, we identified the new isoform ␦ 11 . This isoform is specifically expressed in skeletal muscle tissue and combines the variable regions I from isoforms ␦ 3 and ␦ 9 . Identification of the complete coding sequence of human cardiac ␦ 2 -CaMKII revealed high homology of this kinase between rats and humans.
DCM is a severe disease of the myocardium that generally leads to an enlarged, dilated left ventricle, increased heart rate, and a dramatically reduced ejection fraction. The pathogenesis of the disease seems to be multifactorial, with various causes resulting in the common terminal state of the failing heart. 32 On the molecular level, changes in systems regulating Ca 2ϩ homeostasis as well as in contractile proteins were observed in diseased hearts. 23, 25, 33, 34 CaMKII is critically involved in the regulation of cardiac Ca 2ϩ homeostasis. We investigated in this study the transcript pattern of CaMKII variants of the ␦-class, a CaMKII class that has been Table 2 ). Amounts of transcripts for isoform ␦ 3 and ANF were expressed relative to GAPDH. Asterisks mark values in the DCM group that were significantly different from those in nonfailing hearts (PϽ0.05). Calculated values for individual hearts are given in Table 2 .
presumed to be abundantly expressed in the mammalian myocardium. 18 In addition to the histopathological and clinical characterization of tissue samples obtained from failing and nonfailing hearts, we analyzed ANF transcript level and the protein level of sarcoplasmic reticulum Ca 2ϩ -ATPase. An increase in the amount of ANF mRNA is a commonly accepted marker for heart failure in human and animal models. 27, 35 To our knowledge, however, this is the first attempt to analyze human ANF mRNA levels in nonfailing and DCM hearts by using a semiquantitative RT-PCR technique. Our data confirm the elevation of ANF transcript level in the failing human heart. In contrast to the well-accepted correlation between human heart failure and increased ANF mRNA levels, the reduction in sarcoplasmic reticulum Ca 2ϩ -ATPase in the diseased myocardium has been more controversial. 36 In the present work, we were able to demonstrate a significantly reduced sarcoplasmic reticulum Ca 2ϩ -ATPase level in the DCM group, as has also been described by other investigators. 37, 38 CaMKII is known to be a regulator of gene expression in cardiac myocytes 13 and other cell types. 2, 4, 39, 40 We demonstrated a significant, 1.5-fold increase in the amount of transcript of CaMKII isoform ␦ 3 in failing compared with nonfailing hearts. The enhancement in ␦ 3 transcript level was accompanied by a nearly 2-fold increase in a subclass of ␦-CaMKII protein, to which ␦ 3 belongs. This clearly indicates significant changes in ␦-CaMKII expression in DCM, most likely due to increased levels of isoform ␦ 3 . Ramirez et al 13 demonstrated a positive correlation between expression of CaMKII isoform ␦ 3 , resulting in targeting of the CaMKII holoenzyme to the nucleus, and ANF gene expression in neonatal cardiomyocytes from the rat. The increase in ANF mRNA levels in human heart failure (vide infra and References 26 and 27) and the specific increase of ␦ 3 -CaMKII in DCM as demonstrated here suggest that this mechanism may also be functional in human heart failure. The changes in CaMKII isoform expression at both the mRNA and protein level in DCM may reflect a significant role of this enzyme class for alterations in the gene expression program occurring in human heart failure. Values obtained from individual experiments were normalized to GAPDH expression. Asterisks denote significant values in dilated cardiomyopathy (DCM) hearts compared with the nonfailing (NF) group. ND indicates not determined.
